DISULFIRAM Drug Patent Profile
✉ Email this page to a colleague
When do Disulfiram patents expire, and what generic alternatives are available?
Disulfiram is a drug marketed by Alvogen, Chartwell Molecules, Dash Pharms, Hikma, Sigmapharm Labs Llc, Strides Pharma, Watson Labs, and Watson Labs Teva. and is included in eleven NDAs.
The generic ingredient in DISULFIRAM is disulfiram. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Disulfiram
A generic version of DISULFIRAM was approved as disulfiram by SIGMAPHARM LABS LLC on March 28th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DISULFIRAM?
- What are the global sales for DISULFIRAM?
- What is Average Wholesale Price for DISULFIRAM?
Summary for DISULFIRAM
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Clinical Trials: | 67 |
| Patent Applications: | 3,264 |
| Drug Prices: | Drug price information for DISULFIRAM |
| DailyMed Link: | DISULFIRAM at DailyMed |
Recent Clinical Trials for DISULFIRAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University | N/A |
| College of Pharmaceutical Sciences at Zhejiang University | N/A |
| First People's Hospital of Hangzhou | N/A |
Pharmacology for DISULFIRAM
| Drug Class | Aldehyde Dehydrogenase Inhibitor |
| Mechanism of Action | Acetyl Aldehyde Dehydrogenase Inhibitors |
Medical Subject Heading (MeSH) Categories for DISULFIRAM
Anatomical Therapeutic Chemical (ATC) Classes for DISULFIRAM
US Patents and Regulatory Information for DISULFIRAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | DISULFIRAM | disulfiram | TABLET;ORAL | 091681-001 | Aug 8, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | DISULFIRAM | disulfiram | TABLET;ORAL | 202652-002 | Feb 5, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dash Pharms | DISULFIRAM | disulfiram | TABLET;ORAL | 203916-001 | Mar 4, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
